|
|
||||||||
Thoracic Imaging |
1 From the Departments of Radiology (L.D.M., H.P.M.); Medicine, Division of Pulmonary and Critical Care Medicine (S.M.P., V.F.T.); Pathology (D.N.H., N.G.H.); and Surgery, Division of Cardiothoracic Surgery (R.D.D.); Duke University Medical Center, Box 3808, Erwin Rd, Durham, NC 27710, and the Durham Veterans Administration Hospital, NC (D.N.H., N.G.H.). Received November 27, 1998; revision requested December 29; final revision received March 17, 1999; accepted July 1. Address reprint requests to H.P.M. (e-mail: mcada003@mc.duke.edu).
| Abstract |
|---|
|
|
|---|
MATERIALS AND METHODS: Over 5 years, 21 episodes of respiratory viral infection (parainfluenza [n = 9], respiratory syncytial virus [n = 8], adenovirus [n = 5], influenza [n = 2]) were diagnosed 6727 days (mean, 270 days) after lung transplantation in 20 recipients. Chest radiographs, computed tomographic (CT) images, and clinical records were reviewed.
RESULTS: Sixteen episodes of respiratory viral infection were diagnosed in patients with symptoms of lower respiratory tract infection or acute allograft dysfunction; five were diagnosed in asymptomatic patients. Chest radiographs were abnormal in 11 (52%) episodes; findings included heterogeneous or homogeneous opacities and masslike consolidation. All patients with radiographic abnormalities were symptomatic. Chest radiographs were unchanged from baseline in 10 (48%) episodes; in one, CT revealed findings not depicted at radiography. Adenoviral infection (n = 5) was typically symptomatic, was associated with new radiographic abnormalities, and was rapidly lethal (n = 4). Infection with parainfluenza and/or respiratory syncytial virus was commonly asymptomatic and was not associated with radiographic abnormalities; affected patients had good outcomes.
CONCLUSION: Respiratory viral infections are important causes of morbidity and mortality in lung transplant recipients. Radiographic abnormalities in patients with respiratory viral infections were usually accompanied by symptoms of lower respiratory tract infection. Adenoviral infection was frequently accompanied by progressive pulmonary opacity and fatal outcome.
Index terms: Bronchoscopy Lung, CT, 60.1211 Lung, infection, 60.206, 60.2062, 60.2066, 60.2069, 60.458 Lung, transplantation, 60.458
| Introduction |
|---|
|
|
|---|
Infection remains a major cause of morbidity and mortality in lung transplant recipients. Bacterial pneumonia and opportunistic infection with organisms such as cytomegaloviruses and Aspergillus organisms account for most serious infections after transplantation (25). However, community-acquired respiratory viral infections, such as those caused by respiratory syncytial virus, influenza, parainfluenza, or adenovirus, are increasingly recognized as causes of serious pneumonia in lung transplant recipients (611). While the radiologic features of bacterial, fungal, or cytomegaloviral pneumonia are well known (3), the findings of respiratory viral infection in lung transplant recipients are poorly documented.
The purpose of this study was to review the radiologic findings for respiratory viral infection in our lung transplant population and to correlate these findings with clinical features and outcomes.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Diagnosis of respiratory viral infection was made in 19 episodes on the basis of positive findings from direct fluorescence antibody testing (n = 7), viral culture (n = 11), or both (n = 1) in specimens obtained at bronchoalveolar lavage. Diagnosis of respiratory viral infection was made in two episodes by means of immunoperoxidase staining for adenovirus in specimens obtained at open lung biopsy (n = 1) or at autopsy (n = 1).
Over the study period, all transplant recipients received prophylactic treatment for infection with Pneumocystis carinii, yearly influenza vaccinations, prophylactic treatment for infection with cytomegalovirus (in selected cases), and standard immunosuppressive treatment (6). Routine surveillance fiberoptic bronchoscopy was performed at 1, 3, 6, and 12 months after transplantation. In addition, fiberoptic bronchoscopy with bronchoalveolar lavage or transbronchial biopsy was performed if patients had clinical or radiologic abnormalities at any time after transplantation. All specimens were routinely sent to the laboratory for viral culture. Virus-specific direct fluorescence antibody assays were routinely performed on specimens obtained at bronchoalveolar lavage after January 1995.
Clinical records were available for all patients and were reviewed by one author (S.M.P.) for signs and symptoms at the time of diagnosis, results of pertinent diagnostic tests, response to therapy, and outcome. Clinical symptoms were categorized as those due to lower respiratory tract infection, upper respiratory tract infection, or neither.
Chest radiographs (erect posteroanterior and left lateral [n = 15], supine anteroposterior [n = 3], or erect anteroposterior [n = 3]) were obtained in all patients on the day of diagnostic fiberoptic bronchoscopy. The radiographs were jointly reviewed by two thoracic radiologists (L.D.M., H.P.M.) who were aware that all patients had proved respiratory viral infection but who were unaware of the patient's clinical status at the time the radiograph was obtained; agreement was reached by consensus. The chest radiographs were compared with baseline radiographs and were classified according to pattern (unchanged from baseline, heterogeneous opacities, homogeneous opacities) and distribution of abnormalities. The presence or absence of associated findings, such as pleural effusion or adenopathy, and findings on follow-up chest radiographs were also recorded.
Chest computed tomographic (CT) images that were obtained within 1 week of the documented infection were available for three patients and were also jointly reviewed by the two thoracic radiologists who were aware that all patients had proved respiratory viral infection but who were unaware of the patient's clinical status at the time CT was performed; agreement was reached by consensus. CT findings of ground-glass opacity, consolidation, bronchial wall thickening, and bronchial dilatation and distribution of abnormalities were recorded.
Means were calculated by using Excel, version 5.0 (Microsoft, Redmond, Wash). The Fisher exact test for group comparisons was performed by using SAS, version 6.12 (SAS Institute, Cary, NC).
| RESULTS |
|---|
|
|
|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Infection with parainfluenza and/or respiratory syncytial virus was accompanied by concomitant infection with other pathogens in 43% (six of 14) of the episodes. One patient with an isolated infection caused by parainfluenza had new findings on chest radiographs. Isolated infection with respiratory syncytial virus was not associated with new radiographic findings in any affected patient. Heterogeneous perihilar opacities were noted in one patient with concomitant infections caused by respiratory syncytial virus and cytomegalovirus (Fig 1) and in another patient with concomitant infections caused by respiratory syncytial virus and P boydii (Fig 2).
Adenovirus occurred as the sole pathogen in four (80%) of five affected patients, three of whom had a fulminant, rapidly fatal course. Initial chest radiographs in these three patients showed new abnormalities, which included heterogeneous opacities, focal masslike consolidation, homogeneous opacity, and pleural effusion (Figs 3, 4). Subsequent radiographs in these three patients showed rapid progression to diffuse homogeneous parenchymal opacification. The fourth patient in whom adenovirus was the sole pathogen had a milder clinical course and recovered fully. Initial chest radiographs showed peribronchial opacities (Fig 5) that had resolved on subsequent radiographs. One patient was asymptomatic when infection with adenovirus was diagnosed, and initial radiographs in this patient were unchanged from baseline. However, P aeruginosa was cultured from the bronchoalveolar lavage fluid in this patient, who subsequently died of pseudomonal sepsis.
Influenza virus was isolated from the bronchoalveolar lavage fluid from two patients; parainfluenza virus was cultured from both, and cytomegalovirus was cultured from one. One affected patient developed symptoms of pneumonia 6 days after transplantation and had a rapidly progressive, fatal course (Fig 6).
Eight (40%) of the 20 patients died during the study period. In four patients, death was directly attributed to respiratory viral infection (with adenovirus [n = 3] or parainfluenza and influenza combined [n = 1]). The other deaths were attributed to lymphoproliferative disorder after transplantation (n = 1) or to other infections (n = 3).
Respiratory viruses were the only pathogens isolated in 13 (62%) of the 21 episodes of infection. In these 13 episodes, chest radiographs were unchanged from baseline in seven and were abnormal in six. Of the seven patients with unchanged chest radiographs, one was asymptomatic, three had symptoms of lower respiratory tract infection, and three had symptoms of upper respiratory tract infection; all seven survived. Of the six patients with abnormal chest radiographs, all patients had symptoms of lower respiratory tract infection; four died. This difference in survival was statistically significant (P = .02), as determined by using the Fisher exact test.
| DISCUSSION |
|---|
|
|
|---|
Respiratory viruses, such as adenovirus, respiratory syncytial virus, parainfluenza virus, and influenza virus, uncommonly cause serious infections in the lower respiratory tract in healthy adults. However, in immunocompromised patients, infection occurs with high rates of morbidity and mortality (1315). The role of these agents in causing infection in lung transplant recipients has been appreciated only recently (610).
Twenty (11%) of 176 lung transplant recipients in our series had documented respiratory viral infection during the study period, and four (20%) of these patients died of respiratory viral infection. It is likely that the true incidence of respiratory viral infection in our population was higher than 11% because routine direct fluorescence antibody testing of specimens obtained at bronchoalveolar lavage was not implemented until 1995, which was approximately one-third into the duration of the study. Previously, identification of a virus required culturing, which was slow and difficult. All of our cases were diagnosed after direct fluorescence antibody testing of the bronchoalveolar lavage fluid became routine, and one-third of the cases were diagnosed with findings from direct fluorescence antibody testing alone.
While infection with cytomegalovirus typically occurs in the first few months after transplantation (3,4,11), respiratory viral infection occurred, on average, 9 months after surgery. These data suggest that most respiratory viral infections in lung transplant recipients are community-acquired. However, infection was diagnosed in five patients during their hospitalization for transplantation, which suggests that nosocomial transmission of viruses from infected family members, visitors, or hospital staff also occurs. Because these organisms are thought not to exist as latent infectious agents or as colonizers (with the possible exception of adenovirus), donor-to-recipient transmission is unlikely unless the donor is acutely infected (15).
Parainfluenza and respiratory syncytial viruses were the most common isolates in our study. Affected patients were usually asymptomatic or had very mild clinical symptoms. This experience is in contrast to that of Wendt et al (7) and Holt et al (8), who reported no cases of infection with parainfluenza in asymptomatic lung transplant recipients. The reason for this discrepancy is uncertain but may be due to the increased sensitivity of direct fluorescence antibody testing in the diagnosis of respiratory viral infection compared with that of viral culture alone. Chest radiographs in these patients usually showed either minimal or no new abnormalities. We found that a comparison with baseline radiographs was helpful in the detection of subtle findings such as heterogeneous perihilar opacities or bronchial wall thickening in these patients. More extensive radiographic abnormalities, including diffuse homogeneous consolidation, have been described in immunocompromised patients with respiratory syncytial viral or parainfluenza pneumonia (13,15,16), but these were not seen in our population.
In our series, patients with infections caused by adenovirus were usually acutely ill with symptoms of lower respiratory tract infection. Of the viral pathogens we studied, adenovirus was associated with the highest rate of mortality; three of five affected patients died of adenoviral pneumonia and sepsis. This experience is similar to that of other immunocompromised patients with adenoviral pneumonia (911,13,17). We found the initial radiographic findings in these patients to be variable, but they typically were more extensive than those seen in patients with infections caused by respiratory syncytial virus or parainfluenza. Most affected patients developed progressive, homogeneous consolidation in the allograft over days to weeks. Pleural effusion was an uncommon manifestation and was seen in one (20%) of five affected patients.
Influenza was an uncommon pathogen in our series and was never a sole isolate. The clinical and radiographic manifestations of infection caused by influenza were variable. One patient developed severe pneumonia, which progressed to adult respiratory distress syndrome, and died. The second patient presented with only minimal symptoms, had few radiologic abnormalities, and recovered. This spectrum of findings is similar to that described in the general population (16).
Several patients in our series presented with lower respiratory tract symptoms, had respiratory viral infections that were diagnosed at bronchoscopy, and had chest radiographs that were unchanged from baseline radiographs. Only one of these patients underwent CT, which revealed bronchial wall thickening and ground-glass opacities. It has been suggested that thin-section CT can be useful in immunocompromised patients with normal chest radiographs and suspected infections (18). Had CT been performed in our symptomatic patients who had negative radiographs, it is possible that subtle abnormalities could have been detected. However, it is unlikely that such findings would have substantially altered clinical management. This contention is supported by the fact that all patients, symptomatic or not, with radiographs that were unchanged from those at baseline, did well and did not have clinical deterioration, whereas patients with radiographic abnormalities tended to have a more serious clinical course, and some died.
In summary, our experience emphasizes the importance of diagnosing respiratory viral infection in lung transplant recipients. Respiratory viral infection occurs over a wide time span after transplantation and is manifested in a broad spectrum of clinical and radiologic findings. New radiographic abnormalities in patients with isolated respiratory viral infections appear to be a marker for more severe infection and are associated with unfavorable clinical outcomes. Unfortunately, the radiographic findings for respiratory viral infection are nonspecific, and other causes of clinical deteriorationsuch as edema, adult respiratory distress syndrome, rejection, or infection with bacterial, fungal, or other viral pathogensmust be excluded in these patients.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. S. Krishnam, R. D. Suh, A. Tomasian, J. G. Goldin, C. Lai, K. Brown, P. Batra, and D. R. Aberle Postoperative Complications of Lung Transplantation: Radiologic Findings along a Time Continuum RadioGraphics, July 1, 2007; 27(4): 957 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Milstone, L. M. Brumble, J. Barnes, W. Estes, J. E. Loyd, R. N. Pierson III, and S. Dummer A single-season prospective study of respiratory viral infections in lung transplant recipients Eur. Respir. J., July 1, 2006; 28(1): 131 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chong, K. S. Lee, T. S. Kim, M. J. Chung, M. P. Chung, and J. Han Adenovirus Pneumonia in Adults: Radiographic and High-Resolution CT Findings in Five Patients. Am. J. Roentgenol., May 1, 2006; 186(5): 1288 - 1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Miller Jr. and R. M. Shah Isolated Diffuse Ground-Glass Opacity in Thoracic CT: Causes and Clinical Presentations Am. J. Roentgenol., February 1, 2005; 184(2): 613 - 622. [Full Text] [PDF] |
||||
![]() |
E. Cantu III, J. Z. Appel III, M. G. Hartwig, H. Woreta, C. Green, R. Messier, S. M. Palmer, and R. D. Davis Jr Early Fundoplication Prevents Chronic Allograft Dysfunction in Patients with Gastroesophageal Reflux Disease Ann. Thorac. Surg., October 1, 2004; 78(4): 1142 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Gasparetto, D. L. Escuissato, E. Marchiori, S. Ono, R. L. F. e Silva, and N. L. Muller High-Resolution CT Findings of Respiratory Syncytial Virus Pneumonia After Bone Marrow Transplantation Am. J. Roentgenol., May 1, 2004; 182(5): 1133 - 1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Lau, G. A. Patterson, and S. M. Palmer Critical Care Aspects of Lung Transplantation J Intensive Care Med, March 1, 2004; 19(2): 83 - 104. [Abstract] [PDF] |
||||
![]() |
A. Oikonomou, N. L. Muller, and S. Nantel Radiographic and High-Resolution CT Findings of Influenza Virus Pneumonia in Patients with Hematologic Malignancies Am. J. Roentgenol., August 1, 2003; 181(2): 507 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. McAdams, J. J. Erasmus, and S. M. Palmer Complications (Excluding Hyperinflation) Involving the Native Lung after Single-Lung Transplantation: Incidence, Radiologic Features, and Clinical Importance Radiology, January 1, 2001; 218(1): 233 - 241. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |